Budget Amount *help |
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2013: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2012: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Research Abstract |
GIP is an incretin hormone, which is released from the gut and involved in homeostasis of glucose metabolism though glucose-depedent insulin secretion from pancreatic beta cells. Interestingly, c-terminal truncated short-form GIP is expressed in pancreatic alpha cells. We found expanded short-from GIP expression in the islet of several diabetic animal models. We synthesized modified short-form GIP and confirmed the peptide to be biologically active by the administration to the normal mice. Finally we treated STZ induced diabetic mice with modified short-form GIP and observed the peptide showed potential to suppress the progression to chronic hyperglycemia in the diabetic model.
|